FDA Drug Application (203046) for CODEINE SULFATE by LANNETT HOLDINGS INC

Back to FDA Applications sponsored by LANNETT HOLDINGS INC

Application Number203046
Product Number001
FormTABLET;ORAL
Dosage15MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCODEINE SULFATE
Active IngredientCODEINE SULFATE



Back to FDA Applications sponsored by LANNETT HOLDINGS INC